Livers donated after cardiac death safe for patients with liver cancer

the ONA take:

According to a recent study published in the American Journal of Transplantation, researchers from Mayo Clinic in Jacksonville, Florida, have found that patients with liver cancer have the same positive outcomes using organs donated by patients who died as a result of cardiac death.

For the study, researchers identified 397 patients with liver cancer who received a new liver. Of those, 340 were from a person died after brain death and 57 were donated after cardiac death. Results showed that cancer recurrence occurred in about 12% of patients in both groups.

Previous studies have suggest that livers donated after cardiac death result in worse outcomes in patients with liver cancer because the liver has suffered oxygen deprivation.

"Our program has one of the largest experiences in the world with liver transplants using donations after cardiac death," says the study's lead investigator, transplant surgeon Kristopher P. Croome, M.D. "We now know that these organs effectively offer new life for patients with liver cancer."

Livers donated after cardiac death safe for patients with liver cancer
Patients with liver cancer have the same positive outcomes using organs donated by patients who died as a result of cardiac death.
Patients with liver cancer can be cured with a liver transplant. But because of the shortage of donated organs, these patients often die waiting for a liver. That's because most transplant centers predominantly use livers from donors who die from brain death.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs